Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients.

@article{Patel2012UseOM,
  title={Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients.},
  author={Neil D. Patel},
  journal={Neonatology},
  year={2012},
  volume={102 2},
  pages={130-6}
}
BACKGROUND Pulmonary hypertension and secondary cardiac dysfunction are important contributors of morbidity and mortality in infants with congenital diaphragmatic hernia (CDH). Milrinone, a phosphodiesterase-3 inhibitor, may be useful in this setting for its combined actions as a pulmonary vasodilator and to improve systolic and diastolic function. OBJECTIVES This study aimed to assess the effects of milrinone on cardiac function and pulmonary artery pressure in infants with CDH. METHODS A… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Pulmonary Hypertension and Pulmonary Vasodilators.

Clinics in perinatology • 2016
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Similar Papers

Loading similar papers…